A
| Joy E. Anderson, M.D. | Physical chemistry |
| Barbara Asselin, M.D. | Clinical trials for multiple childhood cancers, specializing in leukemia & lymphoma |
B
| Robert Bambara, Ph.D. | Mechanisms of DNA replication, repair and recombination |
| Richard K. Barth, Ph.D. | Tumor immunology and virology |
| Ravi Basavappa, Ph.D. | Crystallography of proteins involved in cell cycle regulation |
| Swati Basu, M.D. | Coorelation between pediatric hodgkin’s disease and breast cancer |
| Michael Becker, M.D. | Stem cell research in hematology/oncology |
| John M. Bennett, M.D. | Clinical trials for multiple cancers |
| William A. Bernhard, Ph.D. | Effects of radiation on DNA |
| Steven H. Bernstein, M.D. | Development of novel immunotherapeutic approaches to the treatment of patients with lymphoproliferative disorders |
| Neil Blumberg, M.D. | Blood transfusion immunology |
| Dirk Bohmann, Ph.D. | Signals that enable cancer cells to grow |
| William Bonnez, M.D. | The papilloma virus and cervical cancer |
| Andrea Bottaro, Ph.D. | DNA sequences/how immune cells become cancerous |
| William J. Bowers, Ph.D. | Novel antigens that protect against cancer |
| Ralph Brasacchio, M.D. | Genitourinary Tumors; Brachytherapy |
| Lauren Bruckner, M.D., Ph.D. | Pediatrics bone marrow transplant |
| Marc Brown, M.D. | Clinical studies to treat basal cell carcinomaMicrosopically controlled surgery for cutaneous malignancies |
C
| Chawnshang Chang, Ph.D. | Molecular mechanisms of prostate cancer progression |
| Yuhchyau Chen, M.D., Ph.D. | Lung Tumors; Radiosensitization |
| Louis S. (Sandy) Constine, M.D. | Radiation oncology and use of MRI for detecting brain tumors for children |
D
| Stephen Dewhurst, Ph.D. | Cancer vaccine development |
F
| Bruce M. Fenton, Ph.D. | Tumor Oxygenation; Angiogenesis |
| Richard I. Fisher, M.D. | Overall direction of the Cancer Center and clinical trials for multiple cancers |
| Susan Gross Fisher, Ph.D. | Viral etiology of malignancy Conduct and analysis of clinical trials |
| Thomas Foster, M.D., Ph.D. | Imaging methods to characterize tumor oxygenation and tumor environment |
| John G. Frelinger, Ph.D. | T-cell differentiation Tumor immunotherapy |
| Jonathan Friedberg, M.D. | Therapy for follicular lymphoma |
| Patrick Fultz, M.D. | Abdominal imaging |
G
| Barry M. Goldstein, M.D., Ph.D. | Basic enzyme mechanisms. Rational design of anti-tumor and antiviral drugs |
H
| Mary J. Hauk, D.D.S. | Salivary function in long term survivors of cancer |
| Jeffrey Hayes, Ph.D. | DNA repair |
| Jane T. Hickok, M.D. | Cancer Therapeutic Control; Radiation Oncology |
| Russell Hilf, Ph.D. | How hormones effect tumor growthPhotodynamic therapy (PDT), for a variety of malignancies |
| P. M. Hinkle, Ph.D. | Molecular cell regulation Keep tumors from developing resistance to chemotherapy |
| Wei Hsu, Ph.D. | Cell signaling |
| Alissa Huston, M.D. | Treatment of chemotherapy-induced osteoporosis in breast cancer patients Mechanisms of cancer metastasizing to bone |
I
| Jainulabdeen J. Ifthikharuddin, M.D. | Clinical trials for Non-Hodgkin’s lymphoma, leukemia, and multiple myeloma |
J
| Craig Jordan, Ph.D. | A leader in leukemia and stem cell research |
K
| Alan W. Katz, M.D. , M.P.H. | Gastrointestinal Tumors; Brachytherapy |
| Peter C. Keng, Ph.D. | DNA repair and proteins regulating cell cycle |
| Scott D. Kennedy, Ph.D. | Magnetic resonance imaging |
| Manish Kohli, M.D. | Physician & researcher in urology oncology |
| Alok Khorana, M.D. | Tumor angiogenesis |
| Baek Kim | Replicating Viruses for Cancer Therapy |
| Paul D. Kingsley, Ph.D. | The mechanisms that initiate blood cell development |
| Kelly Kita | Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer |
| David N. Korones, M.D. | Childhood Cancers |
L
| Peter LaCelle, Ph.D. | Hematologic Disorders – Leukemia, Sickle Cell |
| Hartmut Land, Ph.D. | The molecular basis of oncogene co-operation, cell cycle control and signal integration mechanisms |
| Christopher W. Lawrence, Ph.D. | DNA-damage resulting in mutagenesis |
| Willis Li, Ph.D. | Cell signaling |
| Jane Liesveld, M.D. | Growth factor regulation of bone marrow cells.Clinical trials for leukemia and non-Hodgkin’s lymphoma |
| Marilyn N. Ling, M.D. | Breast cancer |
| Haisong Liu | Improve accuracy of radiation techniques / Image Segmentation; Brachytherapy |
| Edith M. Lord, Ph.D. | Immune responses which can control tumor development |
M
| Sanjay Maggirwar, Ph.D. | Lung inflammation and lung cancer |
| Mahin D. Maines, Ph.D. | Cell Cycle and Cell Signaling Pathways |
| Lynne E. Maquat, Ph.D. | Biochemistry / BiophysicsRNA metabolism in human disease, studies focused on RNA decay pathway |
| Margot Mayer-Proschel, Ph.D. | Biological and molecular mechanisms governing precursor cell division, differentiation and survival in the brain |
| Carl McGary, M.D., Ph.D. | The metastatic process |
| Scott McIntosh, Ph.D. | Self-help interventions for smoking cessation and behavioral change with various populations |
| Edward Messing, M.D. | Early detection, prevention, and treatment of urologic malignancies |
| Craig Miller, M.D., Ph.D. | Developing therapeutic strategies for treating cutaneous malignancies, specializing in cutaneous T-cell lymphomas |
| L. Milner, M.D. | Research Interests: Hematopoiesis and Stem Cell Biology |
| Hiroshi Miyamoto, M.D., Ph.D. | Cancer biologyProteins in prostate cancer |
| Robert A. Mooney, Ph.D | Dysregulation of tyrosine kinase receptors in type 2 diabetes and breast cancer |
| Gary Morrow, Ph.D. | Cancer control and clinical trials |
| Tim Mosmann, Ph.D. | Immune regulation by T-cell subsets and their cytokines |
| Deborah Mulford, M.D. | Clinical research in leukemia |
| Karen Mustian, Ph.D. | Cancer Therapeutic Control; Exercise and Sport Psychology/Physiology |
N
| Mark Noble, Ph.D. | Stem cell biologyEliminating cognitive impairment associated with the treatment of brain tumors |
O
| Walter O’Dell, Ph.D. | Heart Motion Modeling; MRI Motion Tracking |
| Regis O’Keefe, M.D. | Orthopaedic oncology (bone and soft tissue tumors) |
| Paul Okunieff, M.D. | Radiation oncology, specializing in urologic, gastrointestinal and neurologic cancers; supervisor of the Orange Service, which includes high dose brachytherapy, 3D treatment planning, and stereotactic radiosurgery; clinical protocols include an oligometastasis protocol for curative radiosurgical treatment of metastatic breast cancer; Translational Research Chair of the RTOG |
| Deborah J. Ossip-Klein, Ph.D. | Behavioral medicine; health impact of lifestyle changes with particular focus on cigarette smoking, obesity, aging, child/adolescent outcomes measurement, and community intervention |
P
| James Palis, M.D. | Pediatric hematology/oncology |
| Kishan Pandya | Breast, lung, gastrointestinal cancers and prevention |
| Kevin J. Parker, Ph.D. | Sonoelastography and detection of prostate cancer |
| James Peacock, M.D. | Surgical oncology |
| Alice P. Pentland, M.D. | The role of phospholipases and cycloxgenases in epidermal function |
| Gordon L. Phillips, M.D. | Stem cell transplantation for leukemia, lymphoma and multiple myeloma |
| Richard Phipps, Ph.D. | Injury to the lung from exposure to chemotherapeutic agentsControl of malignant lymphoma cells and regulation of antibodyProducing lymphocytes by prostaglandins |
| Robert H. Pierce | Oxidative stress in tissue injury and neoplasia |
| Colin Poulter, M.D. | Radiology |
| J. Edward Puzas, Ph.D. | Molecular and cellular biology of the skeletal system |
Q
R
| Jay Reeder | Causes, treatment and prevention of bladder cancer |
| Richard Reichman, M.D. | Human Papillomavirus (HPV) and Human Immunodeficiency virus infections (HIV) |
| Jacques Robert, Ph.D. | Evolution of immune surveillance; thymocyte differentiation and thymic tumorigenesis |
| Joe Roscoe, M.D. | Design and analysis of research studies concerned with the therapeutic side effects of cancer treatment and patient quality of life |
| Robert Rose, Ph.D. | Human papillomavirus vaccines |
| Randy Rosier, M.D., Ph.D. | Regulation of endochondral ossification |
| Deborah J. Rubens, M.D. | 3D Sonoelastography Imaging for Prostate Cancer |
| Philip Rubin, M.D. | Radiation oncology |
S
| Deepak Sahasrabudhe, M.D. | Urologic oncology |
| Olle Jane Z. Sahler, M.D. | Psychosocial adaptation to childhood cancer; complimentary medicine therapies |
| Michael Schell, Ph.D. | Dr. Schell has been responsible for introducing stereotactic radiosurgery, CT/MRI image correlation and 3D treatment planning |
| Linda M. Schiffhauer, M.D. | Protein expression in breast cancer |
| Glynis Scott, M.D. | Melanocyte biology and melanocyte tumors |
| Benjamin Segal, M.D. | Immune-central nervous system interactions: autoimmunity and tumor immunotherapy |
| George B. Segel, M.D. | Chronic leukemia; control of cell maturation |
| Alan E. Senior, Ph.D. | Preventing tumors from developing resistance to chemotherapy |
| Abhay Ramchandra Shelke, M.D. | Quality of life issues in cancer patients receiving both chemotherapy and radiotherapy |
| Alice Sijts, Ph.D. | Antigen processing by IFN-induced proteasomes and T-cell immunity |
| Patricia Sime, M.D. | Modulation of pulmonary inflammatory using gene transfer techniques |
| Patricia J. Simpson-Haidaris, Ph.D. | Breast and Lung Cancer |
| Alan V. Smrcka, Ph.D. | Molecular mechanisms of signal transductions |
| Yin Sun, Ph.D. | The process of tumor suppression |
T
| Muammar Tasbas, M.D. | Radiation oncology |
| John H. Tu, M.D. | Dermatology |
U
V
W
| Nancy Wang, Ph. D. | Cancer cytogenetics; tumor suppression gene identification for human ovarian cancer |
| Thomas Watson, M.D. | Surgical oncology |
| Gene E. Watson II, D.D.S., M.S., Ph.D. | Diagnosis, treatment and prevention of diseases of salivary glands and salivary gland hypofunction |
| Jacqueline P. Williams, Ph.D. | Radiation Biology; Late Effects |
X
Y
| Fay Young, M.D. | How abnormal maturation of lymphocytes may lead to malignancies such as lymphoma. |
Z
| Sayeeda B. Zain, Ph.D. | Tumor progression and metastases |
| Jiyong Zhao, Ph.D. | How cellular proliferation is regulated |
| Jianhui Zhong, Ph.D. | Molecular oncology and cancer biology |